Coronary Artery Disease in Patients Undergoing Transvalvular Aortic Valve Implantation

Coronary artery disease (CAD) is common in patients with severe aortic stenosis. With the advent of transcatheter aortic valve implantation (TAVI) as a therapeutic option, management of CAD in such patients has undergone a revolution. Younger patients are now candidates for treatment, and have a greater life-time probability of requiring post-TAVI coronary access. Considerations include pre-procedural assessment and revascularisation, procedural planning to avoid coronary obstruction as well as optimisation of post-procedural coronary access. The authors review the challenges of managing CAD in TAVI patients, shed light on the evidence base, and provide guidance on how to optimise management

Cardiology Training in Singapore During the COVID-19 Pandemic

10.1097/ACM.0000000000003570ACADEMIC MEDICINE9511E2-E

Prevalence, risk factors and intervention for depression and anxiety in pulmonary hypertension: a systematic review and meta-analysis

Current guidelines recommend psychological support for patients with pulmonary hypertension suffering from psychological adversity. However, little is known about the prevalence and risk factors of depression and anxiety in patients with pulmonary hypertension (PH).Published versio

Does pulmonary artery pulsatility index predict mortality in pulmonary arterial hypertension?

10.1002/ehf2.13450ESC HEART FAILURE853835-384